Simulations Plus Inc.

Simulations Plus Inc.

SLP

Get informed when a big investor buys or sells

+ Follow
Market Cap$368.7M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Simulations Plus Inc.Simulations Plus Inc.44.5-6%4.6-
$18.50

Target Price by Analysts

1.4% upsideSimulations Plus Target Price DetailsTarget Price
$24.16

Current Fair Value

32.4% upside

Undervalued by 32.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$368.70 Million
Enterprise Value$339.40 Million
Dividend Yield$0.24 (-)
Earnings per Share$-3.22
Beta1.31
Outstanding Shares20,170,000

Return

Return on Equity5.83%ROE
Return on Assets5.30%
Return on Invested Capital-46.36%

Valuation & Multiples

P/E Ratio44.49P/E Ratio
PEG-42.24PEG
Price to Sales4.56Price to Sales
Price to Book Ratio3.04Price to Book Ratio
Enterprise Value to Revenue4.14
Enterprise Value to EBIT-5.25
Enterprise Value to Net Income41
Total Debt to Enterprise0.02
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 13, 2026
EPS Estimate
$0.23
Average shareholder expectation
Revenue Estimate
$20.92 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$0.14
Average shareholder expectation
Revenue Estimate
$17.59 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 6.60%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.66% 78.43%
Total Invested$6.12M 96.80%
Investors Holding16 144.00%

ESG Score

No data

About Simulations Plus Inc.

108 employees

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...